GAI
AVNS

General American Investors’s Avanos Medical AVNS Stock Holding History

General American Investors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-177,119
Closed -$7.17M – 60
2015
Q2 		$7.17M Buy
+177,119
New +$7.95M 0.59% 49

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

General American Investors's AVNS Position: Q3 2015 in Review

General American Investors sold out of Avanos Medical (AVNS) in Q3 2015, closing a stake of 177,119 shares — an estimated $7.17M sold.

General American Investors first reported a position in AVNS in Q2 2015 and held it in 1 quarter. The position peaked at $7.17M in Q2 2015. 353 funds tracked by Wall St. Rank hold AVNS as of Q3 2015.

  • General American Investors reported no remaining Avanos Medical position as of Q3 2015 after selling out during the quarter.
  • General American Investors sold 177,119 Avanos Medical shares in Q3 2015, an estimated $7.17M.
  • General American Investors first reported a position in Avanos Medical in Q2 2015 and held it in 1 quarter.
  • General American Investors's Avanos Medical position peaked at $7.17M in Q2 2015.
  • 353 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2015.

Based on General American Investors's 13F filing for Q3 2015, filed 21 Oct 2015.